Related references
Note: Only part of the references are listed.Hepatitis C and human immunodeficiency virus coinfection in the era of direct-acting antiviral agents: No longer a difficult-to-treat population
Cameron Sikavi et al.
HEPATOLOGY (2018)
Eradication of Hepatitis C Virus and Non-Liver-Related Non-Acquired Immune Deficiency Syndrome-Related Events in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
Juan Berenguer et al.
HEPATOLOGY (2017)
Peripheral blood HIV-1 DNA dynamics in antiretroviral-treated HIV/HCV co-infected patients receiving directly-acting antivirals
Gabriella Rozera et al.
PLOS ONE (2017)
Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection
Claudia Mascia et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2017)
Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation
Rajesh T. Gandhi et al.
PLOS PATHOGENS (2017)
Changes in inflammatory biomarkers in HCV-infected patients undergoing direct acting antiviral-containing regimens with or without interferon
Claudia Mascia et al.
PLOS ONE (2017)
Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns
Francesca Falasca et al.
BMC INFECTIOUS DISEASES (2017)
Soluble CD163 predicts incident chronic lung, kidney and liver disease in HIV infection
Ditte M. Kirkegaard-Klitbo et al.
AIDS (2017)
The macrophage activation marker CD163 is associated with IL28B genotype and hepatic inflammation in chronic hepatitis C virus infected patients
G. Dultz et al.
JOURNAL OF VIRAL HEPATITIS (2016)
Systemic inflammation and liver damage in HIV/hepatitis C virus coinfection
K. V. Shmagel et al.
HIV MEDICINE (2016)
Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1-Infected Individuals
Troels Bygum Knudsen et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy
Lenche Kostadinova et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Current status and prospects of HIV treatment
Tomas Cihlar et al.
CURRENT OPINION IN VIROLOGY (2016)
Association of microbial translocation biomarkers with clinical outcome in controllers HIV-infected patients
Agathe Leon et al.
AIDS (2015)
Long-Term Treatment Outcomes of Patients Infected With Hepatitis C Virus: A Systematic Review and Meta-analysis of the Survival Benefit of Achieving a Sustained Virological Response
Bryony Simmons et al.
CLINICAL INFECTIOUS DISEASES (2015)
Strong and persistent correlation between baseline and follow-up HIV-DNA levels and residual viremia in a population of naive patients with more than 4 years of effective antiretroviral therapy
S. G. Parisi et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
HIV Replication at Low Copy Number and its Correlation with the HIV Reservoir: A Clinical Perspective
Loredana Sarmati et al.
CURRENT HIV RESEARCH (2015)
Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus
Raymond T. Chung et al.
HEPATOLOGY (2015)
Interleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral Reservoir
Jesper F. Hojen et al.
MOLECULAR MEDICINE (2015)
HIV-1 DNA Decay Dynamics in Blood During More Than a Decade of Suppressive Antiretroviral Therapy
Guillaume J. Besson et al.
CLINICAL INFECTIOUS DISEASES (2014)
Soluble CD163, a Macrophage Activation Marker, Is Independently Associated With Fibrosis in Patients With Chronic Viral Hepatitis B and C
Konstantin Kazankov et al.
HEPATOLOGY (2014)
Factors associated with a low HIV reservoir in patients with prolonged suppressive antiretroviral therapy
Slim Fourati et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Structural Basis for Inflammation-driven Shedding of CD163 Ectodomain and Tumor Necrosis Factor-α in Macrophages
Anders Etzerodt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The Effect of Hepatitis C Virologic Clearance on Cardiovascular Disease Biomarkers in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
Kara W. Chew et al.
OPEN FORUM INFECTIOUS DISEASES (2014)
Cell-Based Measures of Viral Persistence Are Associated With Immune Activation and Programmed Cell Death Protein 1 (PD-1)-Expressing CD4+ T cells
Hiroyu Hatano et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir
Grace A. McComsey et al.
AIDS (2012)
Baseline Cellular HIV DNA Load Predicts HIV DNA Decline and Residual HIV Plasma Levels during Effective Antiretroviral Therapy
Saverio Giuseppe Parisi et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
Netanya G. Sandler et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Factors influencing peripheral blood mononuclear cell-associated HIV-1 DNA level after long-term suppressive antiretroviral therapy in 236 patients
Marianne Burgard et al.
AIDS (2009)
HIV-1 Residual Viremia Correlates with Persistent T-Cell Activation in Poor Immunological Responders to Combination Antiretroviral Therapy
Maud Mavigner et al.
PLOS ONE (2009)
Soluble CD163 from activated macrophages predicts mortality in acute liver failure
Holger Jon Moller et al.
JOURNAL OF HEPATOLOGY (2007)
Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults
Mark S. Sulkowski et al.
AIDS (2007)
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
Jason M. Brenchley et al.
NATURE MEDICINE (2006)
Pivotal advance: Activation of cell surface Toll-like receptors causes shedding of the hemoglobin scavenger receptor CD163
Lehn K. Weaver et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Association between cellular human immunodeficiency virus DNA level and immunological parameters in patients with undetectable plasma viremia level during highly active antiretroviral therapy
L Sarmati et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C
L Castéra et al.
GASTROENTEROLOGY (2005)
Modulatory effects of sCD14 and LBP on LPS-host cell interactions
RL Kitchens et al.
JOURNAL OF ENDOTOXIN RESEARCH (2005)
Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: A cross-sectional analysis of the US adult AIDS clinical trials group
KE Sherman et al.
CLINICAL INFECTIOUS DISEASES (2002)